Drugs that contain Sevelamer Hydrochloride
1. Renagel patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6509013 | GENZYME | Method of making phosphate-binding polymers for oral administration |
Aug, 2013
(10 years ago) | |
| US5496545 | GENZYME | Phosphate-binding polymers for oral administration |
Aug, 2013
(10 years ago) | |
| US7014846 | GENZYME | Phosphate-binding polymers for oral administration |
Aug, 2013
(10 years ago) | |
| US7459151 | GENZYME | Phosphate-binding polymers for oral administration |
Aug, 2013
(10 years ago) | |
| US5667775 | GENZYME | Phosphate-binding polymers for oral administration |
Sep, 2014
(9 years ago) | |
| US6733780 | GENZYME | Direct compression polymer tablet core |
Oct, 2020
(3 years ago) | |
Market Authorisation Date: 12 July, 2000
Treatment: Phosphate binding
Dosage: TABLET;ORAL; CAPSULE;ORAL
How can I launch a generic of RENAGEL before it's drug patent expiration?
More Information on Dosage
RENAGEL family patents
